AMI’s annual Specialty Hub Service Providers Report provides comprehensive business intelligence on more than 70 companies
Biopharma companies need to see the employer market clearly in the short and long-term to be able to understand payers management methods for orphan drugs and the impact those decisions will have on their drugs
Oak Hill Capital partnered with Dan Renick to launch Petauri Health, a purpose-built pharmaceutical commercialization services platform
DTx Connect expands AmerisourceBergen’s patient support and market access consulting services, enabling the company to deliver enhanced support across the product lifecycle
The leading commercialization companies are rapidly adding product and service capabilities to offer a robust commercialization portfolio to life science companies
AscellaHealth’s comprehensive portfolio of services results in streamlined access to therapy, optimal clinical results and an enhanced patient journey
Biologics by McKesson continues to solidify its leadership position a provider for limited and exclusive drugs in the specialty pharmacy market
EVERSANA, the leading provider of global services to the life sciences industry, continues to use proven integrated commercialization strategies driven by cutting-edge technologies and faster, real-time data